Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Nov 12, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The COMPKT program is a clinical trial designed to help people who are waiting for a kidney transplant and are dealing with obesity. The study will test a program that combines education on healthy weight loss with technology tools to support making better lifestyle choices. The goal is to see if this approach can help patients improve their health before they receive a transplant.
To be eligible for this study, participants must be on the waiting list for a kidney transplant at VCUHS and have a body mass index (BMI) greater than 35, which indicates obesity. This trial is open to adults aged 65 to 74 and does not discriminate based on gender. Participants can expect to receive helpful resources and support to manage their weight as part of this program. It’s important to note that children, prisoners, and pregnant women are not eligible to join the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • on the waiting list for kidney transplant at VCUHS
- • BMI greater than 35 kg/m2
- Exclusion Criteria:
- • Children, prisoners, pregnant women
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Trial Officials
Evan Sisson
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported